Evidence USA is the America's largest and most holistic event on the use of real world outcomes
for pharmaceutical products: an exhibition, a series of seminars, and a multi track strategic conference.
Top reasons to attend:
Understand the impact of real world evidence on the future healthcare environment
Design and execute successful real world trials
Get big value from your big data: collection, interpretation and communication strategies
Understand stakeholder demands from real world evidence
Revolutionize patient access to valuable medicines
Demonstrate compelling value propositions in the US and globally
Review the enabling technologies in evidence generation
Use observational research to demonstrate value
Last year's event saw over 200 attendees, 40 industry speakers, and 20+ hours of dedicated networking opportunities.
Mr Brian Sweet, Executive Director, US Payer and Real World Evidence, AstraZeneca
Mr John Graham, Executive Director of Lead U.S. Health Economics and Outcomes Research, B.M.S.
Mr Tony Hebden, VP of HEOR, Abbvie
Dr Christopher Dezii, Director, Healthcare Quality and Performance Measures, BMS
Suzanne Belinson, Executive Director, Center for Clinical Effectiveness, BCBS
Julia Gaebler, Senior Director, Global Medical Outcomes, Biogen Idec
Download the brochure for the full agenda and speaker line-up
Early bird discount are available, so book early to save.
Ticket price before 12 September: USD 1050, Ticket price before 3 October: USD 1150, Final ticket price after 3 October: USD 1200